The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often at Series A.
Government or public fundsprind.orgRounds from 2026-07-07 to 2026-09-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
ViferaXS A clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors | Series A Verified against 4 of 11 sources | up to €12M incl. grants | 2026-09-23 | [ LEAD ] |
Proxima Fusion A startup commercializing stellarator fusion | Series A |
| $469.9M |
| 2026-07-07 |
| [ PART ] |